Tag:
Axiron
Latest Headlines
Latest Headlines
Men flock to testosterone meds from Abbott, Lilly
Are testosterone drugs another hormone-replacement ordeal in the making? Some doctors think so, Bloomberg reports.
Lilly, Acrux win FDA OK for testosterone treatment
Shares of Australia's Acrux surged overnight after the biotech and its Big Pharma partner Eli Lilly ( $LLY ) announced that the FDA had approved their new underarm testosterone lotion. The approval
Promising Phase III data clears Acrux's path to the FDA
Australia's Acrux has lived up to analysts' expectations, reporting that its late-stage trial of a new testosterone spray proved promising, which clears the way to an FDA application later this year.
